Effect of Milnacipran in Chronic Neuropathic Low Back Pain
| Status: | Archived |
|---|---|
| Conditions: | Back Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | October 2010 |
| End Date: | December 2011 |
An Exploratory Randomized Placebo Controlled Trial of Milnacipran in Patients With Chronic Neuropathic Low Back Pain
Low back pain is a public health problem affecting between 70-85% of adults at some time in
their life. This study is being done to study the safety and effectiveness of the drug
Milnacipran in treating chronic low back pain.
This exploratory study aims to evaluate Milnacipran in individuals with chronic neuropathic
low back pain. A sample of 40 individuals with chronic low back pain will be enrolled in a
double-blind, randomized, parallel group study comparing twice daily administration of
milnacipran with placebo (total 100 mg bid-or equivalent placebo dosing). The study will
last 6 weeks with subjects being evaluated at the start of the study, at the end of a
one-week drug-free period, and at 1, 2 and 6 weeks of treatment. Additionally, subjects
will evaluated after treatment has ended. Both standard endpoint outcome measures as well
as validated daily self-report measures of pain and activity/disability will be utilized.
We found this trial at
2
sites
Rehabilitation Institute of Chicago The Rehabilitation Institute of Chicago (RIC) is an independent, 501(c)3, non-profit...
Click here to add this to my saved trials
Northwestern University Northwestern is recognized both nationally and internationally for the quality of its educational...
Click here to add this to my saved trials